정자은행 시장 : 서비스 유형별, 기증자별, 기술별, 최종 용도별 예측(2024-2032년)

The Sperm Bank Market size will exhibit 3.8% CAGR during 2024-2032, driven by the rising prevalence of infertility. According to WHO, approximately 17.5% of the adult population, or roughly 1 in 6 individuals worldwide, experience infertility. Infertility affects approximately 10-15% of couples globally, with factors such as delayed parenthood, lifestyle changes, environmental influences, and health conditions contributing to the incidence. This has led to a heightened demand for assisted reproductive technologies (ART) and fertility treatments. Increased utilization of services, including sperm donation, preservation, and genetic consultation is stimulating the market growth.

Enhanced cryopreservation techniques are revolutionizing the sperm bank industry, leading to improved preservation and storage of sperm samples. These advancements include the development of vitrification methods, which minimize ice crystal formation and reduce cellular damage during the freezing process. Additionally, innovations in cryoprotectant solutions are providing better protection for sperm cells, enhancing their viability upon thawing. Automated freezing and thawing systems are also becoming more prevalent, ensuring consistent and optimal preservation conditions. These improvements are significantly increasing the success rates of assisted reproductive technologies (ART) by maintaining higher quality and motility of preserved sperm.

The sperm bank industry is classified based on service type, donor, technique, end-use and region.

The genetic consultation segment will grow rapidly through 2032, as this service is crucial for individuals and couples who are concerned about passing on genetic disorders to their children. By providing comprehensive genetic screening and counseling, sperm banks can help clients make informed decisions and choose donors with favorable genetic profiles. This not only enhances the safety and success rates of ART procedures but also addresses the growing demand for personalized and precision medicine in reproductive health.

Clinics segment will expand at a fast pace through 2032, as they collaborate with sperm banks to offer a range of services, including sperm donation, intrauterine insemination (IUI), in vitro fertilization (IVF), and genetic screening. The partnership between sperm banks and fertility clinics ensures that clients receive comprehensive care, from initial consultation to successful conception. Clinics leverage the expertise of sperm banks in donor recruitment, screening, and preservation to provide high-quality fertility solutions to their patients. The increasing number of fertility clinics worldwide, coupled with their advanced infrastructure and skilled healthcare professionals, is favoring the market outlook.

Europe sperm bank industry will grow at a steady pace through 2032, driven by supportive regulatory frameworks, high acceptance of ART procedures, and advanced healthcare infrastructure. Countries such as the United Kingdom, Denmark, and Spain are at the forefront, offering state-of-the-art fertility services and attracting clients from across the region and beyond. A strong emphasis on R&D, with numerous clinical studies and trials aimed at improving ART outcomes and expanding the range of available treatments, will bolster the industry growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing demand for assisted reproductive technologies (ART)
    • 3.2.1.2 Rising awareness and education initiatives
    • 3.2.1.3 Growing educational and career pursuits are delaying childbearing
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Stringent regulatory landscape
    • 3.2.2.2 High cost associated with these services
• 3.3 Growth potential analysis
• 3.4 Technological landscape
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Service Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Sperm storage
• 5.3 Semen analysis
• 5.4 Genetic consultation

Chapter 6 Market Estimates and Forecast, By Donor, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Known donor
• 6.3 Anonymous donor
• 6.4 ID disclosure donor

Chapter 7 Market Estimates and Forecast, By Technique, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Donor insemination
• 7.3 In-vitro fertilization

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals and clinics
• 8.3 Fertility clinics and centers
• 8.4 Research institutes and laboratories
• 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 California Cryobank
• 10.2 CryoChoice
• 10.3 CryoGam Colorado
• 10.4 Cryos International
• 10.5 European Sperm Bank
• 10.6 Fairfax Cryobank
• 10.7 Fairfax Cryobank
• 10.8 London Sperm Bank
• 10.9 Manhattan Cryobank
• 10.10 Midwest Sperm Bank
• 10.11 New England Cryogenic Center
• 10.12 NW Cryobank
• 10.13 Seattle Sperm Bank
• 10.14 The Sperm Bank of California
• 10.15 Xytex